Quantbot Technologies LP Ligand Pharmaceuticals Inc Transaction History

Quantbot Technologies LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$61.72 - $96.74 $87,704 - $137,467	1,421 New	1,421 $94,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $8,739 - $13,943	-92 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$127.69 - $165.85 $7,661 - $9,951	60 Added 187.5%	92 $14,000
Q3 2021 Nov 09, 2021	BUY	$102.33 - $144.73 $3,274 - $4,631	32 New	32 $4,000
Q4 2020 Feb 12, 2021	SELL	$80.55 - $106.05 $62,829 - $82,719	-780 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$89.56 - $126.72 $57,945 - $81,987	647 Added 486.47%	780 $74,000
Q2 2020 Aug 13, 2020	BUY	$68.28 - $123.65 $8,466 - $15,332	124 Added 1377.78%	133 $14,000
Q1 2020 May 13, 2020	SELL	$63.37 - $107.88 $44,105 - $75,084	-696 Reduced 98.72%	9 $0
Q4 2019 Feb 10, 2020	SELL	$96.94 - $113.59 $71,929 - $84,283	-742 Reduced 51.28%	705 $73,000
Q3 2019 Nov 12, 2019	BUY	$86.25 - $120.16 $124,803 - $173,871	1,447 New	1,447 $144,000
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $10,738 - $12,934	-100 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$105.93 - $142.47 $215,779 - $290,211	-2,037 Reduced 95.32%	100 $12,000
Q4 2018 Feb 13, 2019	BUY	$128.36 - $272.13 $274,305 - $581,541	2,137 New	2,137 $289,000

262

18M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.